Tony Kingsley

Chief Executive Officer, Stablix

About

Male

Tony Kingsley is the Independent Non-Executive Director of Indivior. Tony Kingsley is the CEO of Stablix. Tony Kingsley attended the Harvard Business School.

Experience

Stablix

Chief Executive Officer

View →

Series A23New York, New York, United StatesBiotech/Pharma · Biotechnology

Stablix

Chief Executive Officer · 2022 – present

View →

Series A23New York, New York, United StatesBiotech/Pharma · Biotechnology

Independent Non-Executive Director · Indivior
2025 – present

Education

Dartmouth College · Government
Harvard Business School · MBA

Headlines from Google News. Social posts load from the platform only when you open a tab.

Indivior Appoints Tony Kingsley to the Board of Directors
citybiz · Jun 24
Stablix and Vertex Establish Strategic Collaboration to
GlobeNewswire · Apr 25
Stablix Appoints Douglas Williams, Ph.D., to Board of Directors
GlobeNewswire · Jan 18
Biogen whistle-blower who received $266 million said people who report wrongdoing are ‘an anomaly’
The Boston Globe · Dec 3
Celgene, Acceleron alum Backstrom tapped to be the top purveyor at Scholar Rock
Fierce Biotech · Sep 20

People at Stablix

Brian Bowman

Co-founder, Head of In vitro Pharmacology

Carlo Rizzuto

Interim CEO

Henry Colecraft

Data from: crunchbase